Teva Pharmaceutical Industries, Ltd.
NYSE TEVA · Tel Aviv, Israel
Works in Dermatology · Immunology · Metabolic & endocrine · Musculoskeletal · Neurology
Teva Pharmaceutical Industries, Ltd. is a clinical trial sponsor based in Tel Aviv, Israel, listed as NYSE TEVA. It has no active clinical trials as lead sponsor; its trials since 2021 were across 5 therapeutic areas. Since 2021 it has completed 2 trials and stopped 1 early.
Trial track record · since 2021
Financials · NYSE TEVA
Fundraising
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
On the market
13 approved drug applications with a product on the market.
Questions about Teva Pharmaceutical Industries, Ltd
Teva Pharmaceutical Industries, Ltd has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 2 trials and stopped 1 early.
Teva Pharmaceutical Industries, Ltd is based in Tel Aviv, Israel and is listed as NYSE TEVA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Teva Pharmaceutical Industries, Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2022-08-03.
Approve Suite is not affiliated with Teva Pharmaceutical Industries, Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.